+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Cholangitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767598
  • Report
  • April 2019
  • Region: Global
  • 124 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Albireo Pharma Inc
  • Allergan Plc
  • Celgene Corp
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • MORE
The global clinical trial report- “2019 Cholangitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Cholangitis. It presents in-depth analysis of Cholangitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cholangitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Cholangitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Cholangitis

The research work is prepared through extensive and continuous research on Cholangitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Cholangitis patients are identified
  • The report includes panorama of Cholangitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Cholangitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Albireo Pharma Inc
  • Allergan Plc
  • Celgene Corp
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Cholangitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Cholangitis Clinical Trials by Region
2.2.2 Average Enrollment of Cholangitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Cholangitis Treatment, 2019

3. Region wise Cholangitis Clinical Trials
3.1 Asia Pacific Cholangitis Clinical Trials by Country
3.2 Europe Cholangitis Clinical Trials by Country
3.3 North America Cholangitis Clinical Trials by Country
3.4 Middle East and Africa Cholangitis Clinical Trials by Country
3.5 South and Central America Cholangitis Clinical Trials by Country

4. Cholangitis Clinical Trial Trends
4.1 Start Year wise Cholangitis Clinical Trials
4.2 Phase wise Cholangitis Clinical Trials
4.3 Trial Status wise Cholangitis Clinical Trials
4.4 Trial Type wise Cholangitis Clinical Trials

5. Cholangitis Average Enrollment Trends
5.1 Average Enrollment in Cholangitis Trials by Year
5.2 Average Enrollment in Cholangitis Trials by Phase
5.3 Average Enrollment in Cholangitis Trials by Status
5.4 Average Enrollment in Cholangitis Trials by Type of Trial

6. Companies Participating in Cholangitis Clinical Trials
6.1 Cholangitis Trials by Sponsor Type
6.2 Cholangitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Cholangitis Trials- Phase 1
7.2 Cholangitis Trials- Phase 2
7.3 Cholangitis Trials- Phase 3
7.4 Cholangitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Cholangitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Cholangitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Cholangitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Cholangitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Cholangitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Cholangitis Clinical Trials and Enrolment
Figure 9: Cholangitis Clinical Trials by Phase
Figure 10: Cholangitis Clinical Trials by Trial Status
Figure 11: Cholangitis Clinical Trials by Type
Figure 12: Cholangitis Clinical Trials by Sponsor Type
Figure 13: Cholangitis Clinical Trials by Leading Sponsors
Figure 14: Cholangitis Average Enrollment by Phase
Figure 15: Cholangitis Average Enrollment by Trial Status
Figure 16: Cholangitis Average Enrollment by Type
Figure 17: Cholangitis- Average Enrolment by Type of Sponsors
Figure 18: Cholangitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Cholangitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Cholangitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Cholangitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Cholangitis Clinical Trials and Enrolment
Table 7: North America - Country wise Cholangitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Cholangitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Cholangitis Average Enrollment by Phase
Table 15: Cholangitis Average Enrollment by Trial Status
Table 16: Cholangitis Average Enrollment by Type
Table 17: Cholangitis- Average Enrolment by Type of Sponsors
Table 18: Cholangitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acorda Therapeutics Inc
  • Albireo Pharma Inc
  • Allergan Plc
  • Celgene Corp
  • Chengdu Brilliant Pharmaceutical Co Ltd
  • Dr. Falk Pharma GmbH
  • Genextra Spa
  • Gilead Sciences Inc
  • Shenzhen HighTide Biopharmaceutical Ltd
  • Sino Biopharmaceutical Ltd
Note: Product cover images may vary from those shown
Adroll
adroll